Skip to main navigation
Skip to search
Skip to main content
University of St Andrews Research Portal Home
Help & FAQ
Home
Profiles
Research output
Datasets/Software
Research units
Projects
Activities
Impacts
Prizes
Press/Media
Student theses
Search by expertise, name or affiliation
H
2
- Antagonist Maintenance versus Helicobacter Pylori Eradication Therapy in Patients with Chronic Duodenal Ulcer Disease: A Prospective Study
A Prach, M Malek, Manouchehr Tavakoli
Centre for Responsible Banking and Finance
Research output
:
Other contribution
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'H
2
- Antagonist Maintenance versus Helicobacter Pylori Eradication Therapy in Patients with Chronic Duodenal Ulcer Disease: A Prospective Study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Duodenum Ulcer
100%
Helicobacter Pylori
100%
Eradication Therapy
100%
H2 Antagonist
100%
Prospective Study
100%
Diseases
100%
Ranitidine
42%
Gastrointestinal System
28%
Short Form 36
28%
Rating Scale
28%
Omeprazole
28%
Quality of Life
14%
Infection
14%
Metronidazole
14%
Penicillin
14%
Clarithromycin
14%
Breathing
14%
Intention-to-Treat Analysis
14%
Maintenance Therapy
14%
Amoxicillin
14%
Urea C 13
14%
Treatment Group
14%
Pharmacology, Toxicology and Pharmaceutical Science
Helicobacter Pylori
100%
Histamine H2 Receptor Antagonist
100%
Prospective Study
100%
Diseases
100%
Duodenum Ulcer
100%
Ranitidine
42%
Omeprazole
28%
Clarithromycin
14%
Treatment Group
14%
Metronidazole
14%
Amoxicillin
14%
Penicillin
14%
Urea C 13
14%
Infection
14%